929360071000036103: Medicinal product unit of use reference set (foundation metadata concept)

SNOMED CT Concept\SNOMED CT Model Component\Foundation metadata concept\Reference set\Simple type reference set\Medicinal product unit of use reference set

Status: current, Primitive. Date: 31-Mar 2011. Module: Australian Medicines Terminology module

Descriptions:

Id Description Lang Type Status Case? Module

3288211000168116 MPUU (medicinal product unit of use) reference set en Synonym Active Case sensitive Australian Medicines Terminology module

965507151000036113 Medicinal product unit of use reference set (foundation metadata concept) en Fully specified name Active Case sensitive Australian Medicines Terminology module

965507161000036111 Medicinal product unit of use reference set en Synonym Active Case sensitive Australian Medicines Terminology module

4351141000168117 <p>Terminology to describe in a health record an abstract concept representing the properties of one or more equivalent Trade Product Units of Use.</p><p>This reference set supports the accurate and unambiguous electronic communication and exchange of medicines information between clinicians for medication management and the recording of adverse reactions.</p><p><b>Target client: </b>NCTS</p> en Definition Active Case sensitive Australian Medicines Terminology module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Medicinal product unit of use reference set	Developed by	Australian Digital Health Agency	true	Inferred relationship	Some	615170453
Medicinal product unit of use reference set	Has licence	SNOMED CT-AU licence	true	Inferred relationship	Some	1364130978
Medicinal product unit of use reference set	Is a	Simple type reference set	true	Inferred relationship	Some

Members

bemotrizinol 1.8% + diethylamino hydroxybenzoyl hexyl benzoate 4% + homosalate 8% + octocrylene 8% + titanium dioxide 2.5% lotion

bendamustine hydrochloride 100 mg injection, vial

bendamustine hydrochloride 25 mg injection, vial

benralizumab 30 mg/mL injection, pen device

benralizumab 30 mg/mL injection, syringe

levodopa 50 mg + benserazide 12.5 mg capsule

levodopa 50 mg + benserazide 12.5 mg dispersible tablet

levodopa 100 mg + benserazide 25 mg capsule

levodopa 100 mg + benserazide 25 mg dispersible tablet

levodopa 100 mg + benserazide 25 mg modified release capsule

levodopa 100 mg + benserazide 25 mg tablet

levodopa 200 mg + benserazide 50 mg capsule

levodopa 200 mg + benserazide 50 mg tablet

bentonite 10% + precipitated sulfur 8% + triclosan 0.1% cream

benzoyl peroxide 5% + bentonite 5% cream

benzalkonium chloride 0.1% + tolnaftate 1% cream

benzalkonium chloride 0.1% + ethanol 66% solution

lidocaine hydrochloride monohydrate 2.5% + benzalkonium chloride 0.1% spray

benzalkonium chloride 0.13% lotion

benzalkonium chloride 0.198% spray

choline salicylate 9% + benzalkonium chloride 0.01% + ethanol 31.7% gel

isopropyl alcohol 76% + benzalkonium chloride 0.13% solution

benzalkonium chloride 0.25% + lidocaine hydrochloride 3% + calamine 20% lotion

benzalkonium chloride 2% + light liquid paraffin 65.1% + triclosan 0.7% bath oil

idoxuridine 0.5% + lidocaine hydrochloride 2% + benzalkonium chloride 0.5% cream

benzalkonium chloride 0.05% cream

benzalkonium chloride 6% + light liquid paraffin 52.5% + triclosan 2% bath oil

benzalkonium chloride conditioner

benzathine benzylpenicillin 1.2 million units (900 mg)/2 mL injection, cartridge

benzathine benzylpenicillin 1.2 million units (900 mg)/2 mL injection, syringe

benzathine benzylpenicillin tetrahydrate 1.2 million units (1016.6 mg)/2.3 mL injection, syringe

benzathine benzylpenicillin tetrahydrate 600 000 units (517 mg)/1.17 mL injection, syringe

benzatropine mesilate 2 mg/2 mL injection, ampoule

benzatropine mesilate 2 mg/2 mL injection, vial

benzatropine mesilate 2 mg tablet

benzocaine 1 mg + cetylpyridinium chloride 1.3 mg + dextromethorphan hydrobromide monohydrate 5 mg + menthol 5.2 mg lozenge

benzocaine 10 mg + cetylpyridinium chloride 1.3 mg lozenge (medicinal product unit of use)

benzocaine 1% spray

phenazone 5.4% + benzocaine 1.4% ear drops

camphor 6.8% + benzocaine 2% + peru balsam 2% + phenol 0.9% ointment

benzocaine 3% + cetrimide 0.5% cream

cetylpyridinium chloride 0.05% + benzocaine 0.4% mouthwash

benzocaine 5% + resorcinol 2% cream

ethanol 22.5% + phenol 10% + benzocaine 5% solution

benzocaine 7.5% + clove bud oil 19% + ethanol 18% solution

cetylpyridinium chloride 1.3 mg + benzocaine 8.2 mg lozenge

benzoic acid 3% + salicylic acid 1.5% ointment

thymol 750 microgram/mL + benzoic acid 4 mg/mL + sodium benzoate 20 mg/mL + sodium bicarbonate 1.5 mg/mL mouthwash

benzoic acid 6% + salicylic acid 3% ointment

thymol 1.5 mg/mL + benzoic acid 8 mg/mL + sodium bicarbonate 3 mg/mL mouthwash

benzoin Sumatra 1% + camphor 1% + storax prepared 0.8% + wool fat 52.4% + zinc oxide 14.3% cream

benzoyl peroxide 10% cream

benzoyl peroxide 10% gel

benzoyl peroxide 10% lotion

benzoyl peroxide 2.5% gel

benzoyl peroxide 4% cream

clindamycin 1% + benzoyl peroxide 5% gel

benzoyl peroxide 5% cream

benzoyl peroxide 5% gel

benzoyl peroxide 5% solution

benzydamine hydrochloride 1.5 mg + cetylpyridinium chloride 1.33 mg + pholcodine 5.5 mg lozenge

benzydamine hydrochloride 0.15% + chlorhexidine gluconate 0.12% mouthwash

benzydamine hydrochloride 0.15% mouthwash

benzydamine hydrochloride 0.15% spray

benzydamine hydrochloride 1% + cetylpyridinium chloride 0.1% gel

benzydamine hydrochloride 3 mg + cetylpyridinium chloride 1.33 mg lozenge

lidocaine hydrochloride 4 mg + benzydamine hydrochloride 3 mg + dichlorobenzyl alcohol 1.2 mg lozenge

lidocaine hydrochloride monohydrate 4 mg + benzydamine hydrochloride 3 mg + dichlorobenzyl alcohol 1.2 mg lozenge

benzydamine hydrochloride 0.3% spray

benzydamine hydrochloride 3 mg lozenge

benzydamine hydrochloride 3% cream

benzydamine hydrochloride 3% gel

benzydamine hydrochloride 5% gel

benzyl alcohol 12 mg + cetylpyridinium chloride 2 mg lozenge

benzyl alcohol 5 mg + cetylpyridinium chloride 1.3 mg lozenge

benzyl alcohol 6 mg + cetylpyridinium chloride 1.3 mg + eucalyptus oil 5 mg + menthol 6 mg lozenge

benzyl alcohol 6 mg + cetylpyridinium chloride 1.3 mg lozenge

zinc oxide 10.75% + peru balsam 1.88% + benzyl benzoate 1.25% ointment

benzyl benzoate 25% lotion

zinc oxide 300 mg + peru balsam 50 mg + benzyl benzoate 33 mg suppository

benzylpenicillin 1.2 g injection, vial

benzylpenicillin 3 g injection, vial

benzylpenicillin 6 g injection, vial

benzylpenicillin 600 mg injection, vial

beractant 200 mg/8 mL intratracheal suspension, vial

besifloxacin 0.6% eye drops

betahistine dihydrochloride 16 mg tablet

betahistine dihydrochloride 24 mg tablet

betahistine dihydrochloride 8 mg tablet

betaine 1 g/g powder for oral liquid

betaine 0.1% + polyaminopropyl biguanide 0.1% solution, ampoule

betaine hydrochloride 50 mg + cellulase 5 mg + pancreatin 100 mg + papain 50 mg + tilactase 5 mg capsule

betaine hydrochloride 650 mg + pepsin 31.5 mg + gentiana lutea 20 mg tablet

betamethasone (as dipropionate) 0.05% lotion

calcipotriol 0.005% + betamethasone (as dipropionate) 0.05% foam

calcipotriol 0.005% + betamethasone (as dipropionate) 0.05% gel

calcipotriol 0.005% + betamethasone (as dipropionate) 0.05% ointment

betamethasone (as dipropionate) 0.05% cream

betamethasone (as dipropionate) 0.05% ointment

betamethasone (as valerate) 0.1% cream

betamethasone (as valerate) 0.1% lotion

Start Previous Page 12 of 75 Next End

Reference Sets

Australian dialect reference set

Reference set descriptor